Adrenocortical carcinoma
Clinical research in adrenocortical carcinoma includes postoperative adjuvant therapy, treatment of advanced and metastatic disease, and maintenance strategies after initial response to systemic therapy. The sponsor’s studies also address combinations built around mitotane, etoposide, cisplatin, and immunotherapy.
- High-risk postoperative management
- Advanced and metastatic disease control
- Maintenance immunotherapy
Interest extends across recurrence prevention, disease stabilization, and therapy intensification in adrenal malignancy.
Hematologic malignancies and transplantation
Research activity in acute myeloid leukemia focuses on allogeneic stem cell transplantation and conditioning regimens in adults with remission-stage disease. The sponsor also supports studies in severe post-transplant complications requiring targeted cellular intervention.
- Acute myeloid leukemia
- Allogeneic stem cell transplantation
- Transplant-related immune complications
These investigations include graft-versus-host disease and refractory inflammatory states after standard immunosuppressive treatment.
Graft-versus-host disease
Within graft-versus-host disease research, the sponsor is involved in adult cases that remain active despite corticosteroid therapy and ruxolitinib. The therapeutic emphasis is on cell therapy and immune-modulating approaches for resistant disease.
- Refractory acute graft-versus-host disease
- Allogeneic mesenchymal stromal cells
- Second-line immune rescue strategies
These studies reflect a focus on severe immune-mediated complications in the transplant setting.
Head and neck cancer and prostate cancer
The sponsor also funds oncology studies in head and neck squamous cell carcinoma and prostate cancer. Research topics include targeted combinations for platinum-resistant disease and treatment strategies integrating stereotactic body radiation therapy with androgen deprivation therapy.
- Head and neck squamous cell carcinoma
- Platinum-resistant solid tumors
- Prostate cancer radiotherapy combinations
These areas show sustained interest in solid tumor treatment optimization across distinct disease settings.
West Nile virus infection
In West Nile virus infection, the sponsor supports clinical research aimed at early outpatient management for patients at risk of progression. The clinical focus is on viremia reduction and control of viral infection in vulnerable individuals.
- West Nile virus
- Early outpatient management
- Progression risk reduction
This infectious disease work adds a virology component to the sponsor’s oncology and transplant portfolio.
